VWM
NVO

Venturi Wealth Management’s Novo Nordisk NVO Stock Holding History

Venturi Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
24,965
-10,387
-29% -$446K 0.05% 200
2026
Q1 		$1.3M Buy
35,352
+1,979
+6% +$93.8K 0.06% 173
2025
Q4 		$1.7M Buy
33,373
+1,265
+4% +$64.7K 0.08% 141
2025
Q3 		$1.78M Buy
32,108
+4,616
+17% +$270K 0.08% 130
2025
Q2 		$1.9M Sell
27,492
-2,137
-7% -$145K 0.09% 125
2025
Q1 		$2.06M Sell
29,629
-1,000
-3% -$82.6K 0.11% 110
2024
Q4 		$2.63M Sell
30,629
-6,603
-18% -$714K 0.13% 96
2024
Q3 		$4.43M Buy
37,232
+5,220
+16% +$696K 0.23% 62
2024
Q2 		$4.57M Buy
32,012
+5,388
+20% +$714K 0.27% 66
2024
Q1 		$3.42M Buy
26,624
+5,136
+24% +$611K 0.22% 71
2023
Q4 		$2.22M Sell
21,488
-2,712
-11% -$268K 0.16% 83
2023
Q3 		$2.2M Sell
24,200
-5,562
-19% -$490K 0.17% 80
2023
Q2 		$2.41M Buy
29,762
+330
+1% +$27K 0.19% 65
2023
Q1 		$2.34M Buy
29,432
+990
+3% +$70.2K 0.19% 73
2022
Q4 		$1.92M Sell
28,442
-2,042
-7% -$120K 0.17% 87
2022
Q3 		$1.52M Buy
+30,484
New +$1.63M 0.15% 92
2022
Q2 		– Sell
-31,322
Closed -$1.74M – 343
2022
Q1 		$1.74M Sell
31,322
-5,382
-15% -$276K 0.13% 90
2021
Q4 		$2.06M Buy
36,704
+1,854
+5% +$100K 0.16% 89
2021
Q3 		$1.67M Buy
34,850
+12
+0% +$580 0.14% 101
2021
Q2 		$1.46M Sell
34,838
-374
-1% -$14.5K 0.13% 110
2021
Q1 		$1.19M Buy
35,212
+5,944
+20% +$212K 0.11% 129
2020
Q4 		$1.02M Buy
29,268
+648
+2% +$22.4K 0.11% 144
2020
Q3 		$993K Buy
28,620
+358
+1% +$11.9K 0.12% 133
2020
Q2 		$925K Buy
28,262
+17,620
+166% +$562K 0.12% 109
2020
Q1 		$320K Buy
10,642
+1,570
+17% +$46.7K 0.05% 178
2019
Q4 		$263K Sell
9,072
-634
-7% -$17.6K 0.03% 215
2019
Q3 		$251K Sell
9,706
-2,062
-18% -$52.1K 0.03% 210
2019
Q2 		$300K Sell
11,768
-3,536
-23% -$87.4K 0.04% 202
2019
Q1 		$399K Sell
15,304
-1,416
-8% -$34.8K 0.05% 171
2018
Q4 		$394K Buy
16,720
+8,060
+93% +$179K 0.06% 159
2018
Q3 		$202K Hold
8,660
– – 0.04% 162
2018
Q2 		$203K Hold
8,660
– – 0.04% 167
2018
Q1 		$213K Sell
8,660
-1,548
-15% -$40.6K 0.04% 168
2017
Q4 		$274K Buy
10,208
+856
+9% +$21.8K 0.05% 176
2017
Q3 		$229K Sell
9,352
-388
-4% -$8.77K 0.05% 176
2017
Q2 		$209K Buy
+9,740
New +$197K 0.05% 175

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Venturi Wealth Management's NVO Position: Q2 2026 in Review

Venturi Wealth Management reduced its Novo Nordisk (NVO) stake by 29% in Q2 2026, selling an estimated $446K and leaving 24,965 shares worth $1.2M. The position accounts for 0.05% of the portfolio, ranked #200.

Venturi Wealth Management first reported a position in NVO in Q2 2017 and has held it in 36 quarters since. The position peaked at $4.57M in Q2 2024. 302 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Venturi Wealth Management held 24,965 shares of Novo Nordisk worth $1.2M as of Q2 2026.
  • Venturi Wealth Management sold 10,387 Novo Nordisk shares in Q2 2026, an estimated $446K.
  • Novo Nordisk made up 0.05% of Venturi Wealth Management's portfolio in Q2 2026, its #200 holding.
  • Venturi Wealth Management first reported a position in Novo Nordisk in Q2 2017 and has held it in 36 quarters since.
  • Venturi Wealth Management's Novo Nordisk position peaked at $4.57M in Q2 2024.
  • 302 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.